Clinical Trials Browser

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

NCT00897273 2019-01-17

Oral HPV Infection in Young Men

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Infections, Oropharyngeal Neoplasms, Precancerous Conditions, Papillomavirus Infections

NCT00899028 2017-04-20

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Completed

689 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02834234 2016-07-26

Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays

Completed

33 enrolled

Other solid neoplasmThoracic

Mesothelioma

NCT00003863 2016-07-06

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Completed

391 enrolled

Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT01169376 2016-05-18

Biomarkers in Young Patients With Neuroblastoma

Completed

380 enrolled

CNS

Neuroblastoma

NCT00003096 2014-08-06

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

Completed

88 enrolled

CNS

Brain Neoplasms, Central Nervous System Neoplasms

NCT00897091 2013-05-30

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

Completed

750 enrolled

Breast

Breast Neoplasms

Clinical Trials

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

Oral HPV Infection in Young Men

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Biomarkers in Young Patients With Neuroblastoma

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil